source
- Beeline Medicines raises $126.3M, bringing total Series A funding to $426.3M for immune‑drug developmentBeeline Medicines announced an additional $126.3 million in Series A financing, pushing the total raised to $426.3 million. The capital boost was disclosed on Tuesday and follows an earlier spring…
- House panel launches probe into Bristol Myers and Pfizer's China trial sitesA congressional committee has opened an inquiry into the use of clinical trial sites in China by Bristol Myers Squibb and Pfizer. The panel is focusing on facilities that the committee chair says…